Phase 1 Study of HRS-9231 Safety and Pharmacokinetics in Healthy Caucasians

NCT06519981 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

MRI

Interventions

DRUG: HRS-9231or matching placebo

Sponsor

Atridia Pty Ltd.